D'Abrosca Reports

Home
Archive
About
New
Top
Community
Why I Ditched Twitter for Good
And why I'm back on Substack.
 • 
Pete D'Abrosca
5
Chinese Pharma Competitor to American Antibody Providers Behind Study Saying Current Antibody Treatments Aren't Effective
Popular American antibody treatments were pulled from the market this week.
 • 
Pete D'Abrosca
2
Today's Top Headlines: 12/31/21
Good morning! It’s New Year’s Eve and here’s what you need to know: 1) AOC flees NYC for the Free State of Florida Slammed 2) Hillary takes shot at…
 • 
Pete D'Abrosca
Today's Top Headlines: 12/30/21
Good morning! It’s Thursday, December 30, 2021 and here’s what you need to know: 1) Smartest woman in “Jeopardy!” history is a man More backlash against…
 • 
Pete D'Abrosca
Today's Top Five Headlines: 12/28/21
Good morning! It’s Tuesday, December 28, 2021 and here’s what you need to know: 1) CDC changes COVID quarantine guidelines Case records smashed by…
 • 
Pete D'Abrosca
An Open Letter to America's Cops
You have more power than you think.
 • 
Pete D'Abrosca
Today's Top Five Headlines: 12/23/21
Good morning! It’s Thursday, December 23, 2021 and here’s what you need to know: 1) MSNBC wants medical apartheid FDA bait and switch on Pfizer…
 • 
Pete D'Abrosca
D'Abrosca Reports
D'Abrosca Reports
Muckraking by Pete D'Abrosca.

D'Abrosca Reports

AboutArchiveSitemap
© 2023 Pete D'Abrosca
Privacy ∙ Terms ∙ Collection notice
Start WritingGet the app
Substack is the home for great writing